Recent progress on the topical therapy of onychomycosis
Authors:
- Stephen J BakerSBStephen J Baker
- Karl R BeutnerKBKarl R Beutner
- Jacob PlattnerJPJacob Plattner
- 24 January 2007
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 16 (2) , 157-167
Abstract
Onychomycosis is a fungal infection of the fingernails and toenails that results in thickening, discoloration, splitting of the nails and lifting of the nail from the nail bed. The disease is caused by dermatophytes and has a high incidence within the general population, especially among older individuals. Present treatment options include both oral and topical drugs, with oral therapies giving better outcomes; however, neither of these treatment options provides high cure rates that are durable. The difficulty in treating onychomycosis results from the deep-seated nature of the infection within the nail unit (nail plate, nail bed and surrounding tissue) and the inability of drugs to effectively reach all sites. Ongoing drug development activities have focused on novel delivery technologies to facilitate penetration of existing antifungal drugs through the nail plate and on the discovery of inherently penetrable antifungals. AN-2690 represents an oxaborole antifungal that is designed to penetrate the nail plate and is showing promising results in clinical trials.Keywords
This publication has 45 references indexed in Scilit:
- Onychomycosis in clinical practice: factors contributing to recurrenceBritish Journal of Dermatology, 2003
- Treatment Failures and Relapses in Onychomycosis: A Stubborn Clinical ProblemDermatology, 2003
- Drug delivery to the nail following topical applicationInternational Journal of Pharmaceutics, 2002
- New developments in chemotherapy for non-invasive fungal infectionsExpert Opinion on Investigational Drugs, 2001
- A large-scale North American study of fungal isolates from nails: The frequency of onychomycosis, fungal distribution, and antifungal susceptibility patternsJournal of the American Academy of Dermatology, 2000
- Prevalence and epidemiology of onychomycosis in patients visiting physicians’ offices: A multicenter Canadian survey of 15,000 patientsJournal of the American Academy of Dermatology, 2000
- Relapses of Onychomycosis after Successful Treatment with Systemic Antifungals: A Three-Year Follow-UpDermatology, 1998
- Prevalence of Onychomycosis in Patients Attending a Dermatology Clinic in Northeastern Ohio for Other ConditionsArchives of Dermatology, 1997
- Terbinafine for the Treatment of Pedal OnychomycosisArchives of Dermatology, 1995
- Bioavailability, Skin‐and Nailpenetration of Topically Applied Antimycotics*Mycoses, 1982